Proposed Procedure for Evaluating Platelet Concentrate Units to Be Used for Transfusion

Abstract

Platelet concentrate samples from 100 units col lected by apheresis at The American Red Cross Blood Bank located at Columbia, S.C. and from 31 units collected by apher esis at The Santa Barbara Tri-County Blood Bank located in Santa Barbara, California were sent overnight to Fishers, Indi ana and tested for platelet factor 3 activity. The maximum dilution that would support normal clotting was determined for each unit. Units with maximum dilutions of 1:100 or greater were considered to have sufficient platelet factor 3 activity to be used for a transfusion. Ninety-six percent of the units sent from Columbia, South Carolina and 94.55% of the units sent from Santa Barbara, California were suitable for use based on their platelet factor 3 activity. This study shows the feasibility of sending platelet concentrates long distances and the impor tance of testing for platelet factor 3 activity.

Keywords

Key Words: Platelet concentrate PF3 Apheresis.

Get full access to this article

View all access options for this article.

References

Office of Medical Applications of Research, National Institute of Health. Perioperative red blood cell transfusion. JAMA 1988;260:2700.

Office of Medical Applications of Research, National Institute of Health. Platelet transfusion therapy . JAMA 1987;257:1777.

Office of Medical Applications of Research, National Institute of Health. Fresh frozen plasma: indications and risk. JAMA 1985;253:551.

American College of Obstetricians and Gynecologists. Blood component therapy, Technical Bulletin No. 78. Washington D.C.: American College of Obstetricians and Gynecologists , 1984.

Goodnough LT , Johnston MF , Ramsey G. , et al. Guidelines for transfusion support in patients undergoing coronary bypass grafting. Ann Thorac Surg 1990;50:675.

American College of Physicians. Practice strategies for elective red blood cell transfusion. Ann Intern Med 1992;116:403.

American College of Pathologists. Practice parameters for the use of fresh-frozen plasma, cryoprecipitates, and platelets. JAMA 1994;271:777.

A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Practice guidelines for blood component therapy. Anesthesiology 1996;84:732.

Speck RE Accurate assay for platelet factor 3. Am Clin Lab 1993;12:16.

10.

Speck RE Coagulation Assays and Reagents. U.S. Patent No. 5,451,509. Issued September 19, 1995.